Home Cart 0 Sign in  

[ CAS No. 1253799-29-9 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
Chemical Structure| 1253799-29-9
Chemical Structure| 1253799-29-9
Structure of 1253799-29-9 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 1253799-29-9 ]

Related Doc. of [ 1253799-29-9 ]

Alternatived Products of [ 1253799-29-9 ]

Product Details of [ 1253799-29-9 ]

CAS No. :1253799-29-9 MDL No. :MFCD28142365
Formula : C35H30FNO3 Boiling Point : -
Linear Structure Formula :- InChI Key :VRXGVVAMXZXKNA-UHFFFAOYSA-N
M.W : 531.62 Pubchem ID :71739305
Synonyms :

Calculated chemistry of [ 1253799-29-9 ]

Physicochemical Properties

Num. heavy atoms : 40
Num. arom. heavy atoms : 30
Fraction Csp3 : 0.11
Num. rotatable bonds : 11
Num. H-bond acceptors : 4.0
Num. H-bond donors : 0.0
Molar Refractivity : 156.93
TPSA : 38.77 Ų

Pharmacokinetics

GI absorption : Low
BBB permeant : No
P-gp substrate : Yes
CYP1A2 inhibitor : Yes
CYP2C19 inhibitor : Yes
CYP2C9 inhibitor : No
CYP2D6 inhibitor : Yes
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -3.6 cm/s

Lipophilicity

Log Po/w (iLOGP) : 4.73
Log Po/w (XLOGP3) : 8.37
Log Po/w (WLOGP) : 8.1
Log Po/w (MLOGP) : 6.64
Log Po/w (SILICOS-IT) : 7.97
Consensus Log Po/w : 7.16

Druglikeness

Lipinski : 2.0
Ghose : None
Veber : 1.0
Egan : 1.0
Muegge : 1.0
Bioavailability Score : 0.17

Water Solubility

Log S (ESOL) : -8.24
Solubility : 0.00000307 mg/ml ; 0.0000000058 mol/l
Class : Poorly soluble
Log S (Ali) : -9.05
Solubility : 0.000000473 mg/ml ; 0.0000000009 mol/l
Class : Poorly soluble
Log S (SILICOS-IT) : -12.9
Solubility : 0.0000000001 mg/ml ; 0.0 mol/l
Class : Insoluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 1.0 alert
Leadlikeness : 3.0
Synthetic accessibility : 3.88

Safety of [ 1253799-29-9 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P261-P305+P351+P338 UN#:N/A
Hazard Statements:H315-H319-H335 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 1253799-29-9 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 1253799-29-9 ]
  • Downstream synthetic route of [ 1253799-29-9 ]

[ 1253799-29-9 ] Synthesis Path-Upstream   1~8

  • 1
  • [ 1207284-89-6 ]
  • [ 100-39-0 ]
  • [ 1253799-29-9 ]
YieldReaction ConditionsOperation in experiment
80%
Stage #1: With N-ethyl-N,N-diisopropylamine In 1-methyl-pyrrolidin-2-one at 100℃; for 18 h; Inert atmosphere
Stage #2: With triethylamine In 1-methyl-pyrrolidin-2-one; water at 8℃; for 0.166667 h; Inert atmosphere
To a solution of 500 g of compound 66 in 4.25 L N-methylpyrolidinone was added N,N-diisopropyIethylamine (620 ml) followed by BnBr (425 mL, 2.5 equiv.). The mixture was heated at 100 0C for 18 h then cooled to 8 0C and treated over 10 min with 25percent w/w aqueous triethyl amine aqueous. The mixture was allowed to stir for 25 minutes at ambient temperature before being cooled to 15 0C adding water (10 L) over ca. 3 hours to precipitate product. The obtained pale colored suspension was filtered then washed with 2 L water and dried. The crude product (750 g) was then dissolved in 4.1 L toluene and filtered through silica gel to give 762 g of a yellow solid that was recrystallized from acetone/heptane to afford 606 g of desired compound 67 (80percent yield) obtained as an off-white solid: 1H NMR (400 MHz, CDCl3) δ 7.48-7.03 (m, 20 H), 6.60 (d, J= 1 1.5 Hz, 1 H), 5.31 (s, 2H), 4.33 (s, 4 H), 2.30 (s, 3H).
Reference: [1] Patent: WO2010/126607, 2010, A2, . Location in patent: Page/Page column 172/251
  • 2
  • [ 220901-72-4 ]
  • [ 1253799-29-9 ]
Reference: [1] Patent: WO2010/126607, 2010, A2,
  • 3
  • [ 1207283-54-2 ]
  • [ 1253799-29-9 ]
Reference: [1] Patent: WO2010/126607, 2010, A2,
  • 4
  • [ 1207283-55-3 ]
  • [ 1253799-29-9 ]
Reference: [1] Patent: WO2010/126607, 2010, A2,
  • 5
  • [ 1207284-87-4 ]
  • [ 1253799-29-9 ]
Reference: [1] Patent: WO2010/126607, 2010, A2,
  • 6
  • [ 1207284-88-5 ]
  • [ 1253799-29-9 ]
Reference: [1] Patent: WO2010/126607, 2010, A2,
  • 7
  • [ 394-04-7 ]
  • [ 1253799-29-9 ]
Reference: [1] Patent: WO2010/126607, 2010, A2,
  • 8
  • [ 100-39-0 ]
  • [ 1253799-29-9 ]
Reference: [1] Patent: WO2010/126607, 2010, A2,
Same Skeleton Products
Historical Records

Pharmaceutical Intermediates of
[ 1253799-29-9 ]

Eravacycline Related Intermediates

Chemical Structure| 394-04-7

[ 394-04-7 ]

5-Fluoro-2-methoxybenzoic acid

Related Functional Groups of
[ 1253799-29-9 ]

Fluorinated Building Blocks

Chemical Structure| 1001346-91-3

[ 1001346-91-3 ]

4-Amino-2-fluoro-5-methoxybenzoic acid

Similarity: 0.74

Chemical Structure| 2106575-50-0

[ 2106575-50-0 ]

5-(5-Fluoro-2-methoxyphenyl)-3-methyl-1H-pyrrole-2-carboxylic acid

Similarity: 0.72

Chemical Structure| 151793-18-9

[ 151793-18-9 ]

Methyl 5-amino-4-fluoro-2-methoxybenzoate

Similarity: 0.70

Chemical Structure| 1235865-75-4

[ 1235865-75-4 ]

Methyl 2-((1H-pyrrolo[2,3-b]pyridin-5-yl)oxy)-4-fluorobenzoate

Similarity: 0.69

Chemical Structure| 651734-52-0

[ 651734-52-0 ]

4-(Benzylamino)-3,5-difluoro-2,6-dimethoxybenzoic acid

Similarity: 0.68

Aryls

Chemical Structure| 1001346-91-3

[ 1001346-91-3 ]

4-Amino-2-fluoro-5-methoxybenzoic acid

Similarity: 0.74

Chemical Structure| 2106575-50-0

[ 2106575-50-0 ]

5-(5-Fluoro-2-methoxyphenyl)-3-methyl-1H-pyrrole-2-carboxylic acid

Similarity: 0.72

Chemical Structure| 151793-18-9

[ 151793-18-9 ]

Methyl 5-amino-4-fluoro-2-methoxybenzoate

Similarity: 0.70

Chemical Structure| 1235865-75-4

[ 1235865-75-4 ]

Methyl 2-((1H-pyrrolo[2,3-b]pyridin-5-yl)oxy)-4-fluorobenzoate

Similarity: 0.69

Chemical Structure| 147770-06-7

[ 147770-06-7 ]

(S)-Ethyl 2-ethoxy-4-(2-((3-methyl-1-(2-(piperidin-1-yl)phenyl)butyl)amino)-2-oxoethyl)benzoate

Similarity: 0.69

Ethers

Chemical Structure| 1001346-91-3

[ 1001346-91-3 ]

4-Amino-2-fluoro-5-methoxybenzoic acid

Similarity: 0.74

Chemical Structure| 2106575-50-0

[ 2106575-50-0 ]

5-(5-Fluoro-2-methoxyphenyl)-3-methyl-1H-pyrrole-2-carboxylic acid

Similarity: 0.72

Chemical Structure| 151793-18-9

[ 151793-18-9 ]

Methyl 5-amino-4-fluoro-2-methoxybenzoate

Similarity: 0.70

Chemical Structure| 1235865-75-4

[ 1235865-75-4 ]

Methyl 2-((1H-pyrrolo[2,3-b]pyridin-5-yl)oxy)-4-fluorobenzoate

Similarity: 0.69

Chemical Structure| 147770-06-7

[ 147770-06-7 ]

(S)-Ethyl 2-ethoxy-4-(2-((3-methyl-1-(2-(piperidin-1-yl)phenyl)butyl)amino)-2-oxoethyl)benzoate

Similarity: 0.69

Esters

Chemical Structure| 151793-18-9

[ 151793-18-9 ]

Methyl 5-amino-4-fluoro-2-methoxybenzoate

Similarity: 0.70

Chemical Structure| 1235865-75-4

[ 1235865-75-4 ]

Methyl 2-((1H-pyrrolo[2,3-b]pyridin-5-yl)oxy)-4-fluorobenzoate

Similarity: 0.69

Chemical Structure| 147770-06-7

[ 147770-06-7 ]

(S)-Ethyl 2-ethoxy-4-(2-((3-methyl-1-(2-(piperidin-1-yl)phenyl)butyl)amino)-2-oxoethyl)benzoate

Similarity: 0.69

Chemical Structure| 924668-99-5

[ 924668-99-5 ]

Methyl 5-fluoro-2-(methylamino)benzoate

Similarity: 0.68

Chemical Structure| 59-06-3

[ 59-06-3 ]

Methyl 4-acetamido-2-ethoxybenzoate

Similarity: 0.68

Amines

Chemical Structure| 1001346-91-3

[ 1001346-91-3 ]

4-Amino-2-fluoro-5-methoxybenzoic acid

Similarity: 0.74

Chemical Structure| 151793-18-9

[ 151793-18-9 ]

Methyl 5-amino-4-fluoro-2-methoxybenzoate

Similarity: 0.70

Chemical Structure| 147770-06-7

[ 147770-06-7 ]

(S)-Ethyl 2-ethoxy-4-(2-((3-methyl-1-(2-(piperidin-1-yl)phenyl)butyl)amino)-2-oxoethyl)benzoate

Similarity: 0.69

Chemical Structure| 651734-52-0

[ 651734-52-0 ]

4-(Benzylamino)-3,5-difluoro-2,6-dimethoxybenzoic acid

Similarity: 0.68

Chemical Structure| 924668-99-5

[ 924668-99-5 ]

Methyl 5-fluoro-2-(methylamino)benzoate

Similarity: 0.68